1. Home
  2. SACH vs IPSC Comparison

SACH vs IPSC Comparison

Compare SACH & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SACH
  • IPSC
  • Stock Information
  • Founded
  • SACH 2010
  • IPSC 2019
  • Country
  • SACH United States
  • IPSC United States
  • Employees
  • SACH N/A
  • IPSC N/A
  • Industry
  • SACH Real Estate Investment Trusts
  • IPSC Medicinal Chemicals and Botanical Products
  • Sector
  • SACH Real Estate
  • IPSC Health Care
  • Exchange
  • SACH Nasdaq
  • IPSC Nasdaq
  • Market Cap
  • SACH 46.7M
  • IPSC 54.7M
  • IPO Year
  • SACH 2017
  • IPSC 2021
  • Fundamental
  • Price
  • SACH $1.09
  • IPSC $0.58
  • Analyst Decision
  • SACH Hold
  • IPSC Strong Buy
  • Analyst Count
  • SACH 3
  • IPSC 5
  • Target Price
  • SACH $2.25
  • IPSC $3.33
  • AVG Volume (30 Days)
  • SACH 216.2K
  • IPSC 868.9K
  • Earning Date
  • SACH 08-13-2025
  • IPSC 08-07-2025
  • Dividend Yield
  • SACH 18.61%
  • IPSC N/A
  • EPS Growth
  • SACH N/A
  • IPSC N/A
  • EPS
  • SACH N/A
  • IPSC N/A
  • Revenue
  • SACH N/A
  • IPSC $114,898,000.00
  • Revenue This Year
  • SACH N/A
  • IPSC $1,064.82
  • Revenue Next Year
  • SACH $4.52
  • IPSC N/A
  • P/E Ratio
  • SACH N/A
  • IPSC N/A
  • Revenue Growth
  • SACH N/A
  • IPSC 8286.72
  • 52 Week Low
  • SACH $0.80
  • IPSC $0.34
  • 52 Week High
  • SACH $3.07
  • IPSC $3.29
  • Technical
  • Relative Strength Index (RSI)
  • SACH 52.20
  • IPSC 52.16
  • Support Level
  • SACH $1.03
  • IPSC $0.58
  • Resistance Level
  • SACH $1.11
  • IPSC $0.66
  • Average True Range (ATR)
  • SACH 0.06
  • IPSC 0.04
  • MACD
  • SACH -0.00
  • IPSC -0.00
  • Stochastic Oscillator
  • SACH 44.07
  • IPSC 41.52

About SACH Sachem Capital Corp.

Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

Share on Social Networks: